ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,203.93
-0.45%
Dow Jones
39,375.87
0.17%
Gold vs US Dollar
2,391.585
1.48%
Brent Oil
86.775
-0.64%
Bitcoin
56,502.55
-0.84%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RVL Pharmaceuticals PLC (RVLP)

  7. RVL Pharmaceuticals PLC (RVLP) News

RVL Pharmaceuticals (RVLP)

RVL Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVLP
DateTimeSourceHeadlineSymbolCompany
17/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
20/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
27/11/202311:50GlobeNewswire Inc.RVL Completes Financial RestructuringNASDAQ:RVLPRVL Pharmaceuticals PLC
16/11/202314:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
01/11/202320:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
23/10/202321:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
23/10/202318:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
20/10/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
20/10/202320:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
20/10/202318:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
18/10/202321:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
13/10/202322:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
13/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
12/10/202311:50GlobeNewswire Inc.RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. SubsidiariesNASDAQ:RVLPRVL Pharmaceuticals PLC
29/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
22/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
05/09/202321:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
05/09/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
05/09/202312:45Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:RVLPRVL Pharmaceuticals PLC
31/08/202319:23Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RVLPRVL Pharmaceuticals PLC
30/08/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVLPRVL Pharmaceuticals PLC
25/08/202322:21Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
25/08/202321:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
23/08/202322:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVLPRVL Pharmaceuticals PLC
23/08/202321:05GlobeNewswire Inc.RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:RVLPRVL Pharmaceuticals PLC
18/08/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
17/08/202322:06Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
17/08/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
17/08/202321:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVLPRVL Pharmaceuticals PLC
16/08/202313:00GlobeNewswire Inc.RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:RVLPRVL Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:RVLP

Your Recent History

BIT
UB4Q6B
Unicredit Bank
BIT
F06351
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved